4[1]Ridker PM,Hennekens CH,Buring JE,et al.C-reactive protein and other markers of inflammation in the prediction of cardiovasular disease in women[J].New Engl J Med,2000,23:836.
5[4]Stewart C,White M,Punnai V,et al.Interleukin-18 enhances atheros clerosis in apolipoprotein E-/-mice through release of interferon-γ[J].Circul Res,2002,90(2):34.
6[5]Tahara H,Oikawa Y,Shimada A,et al.Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice[J].J Immunol,2003,171:5865-5875.
7[6]Aso Y,Okumura KI,Takebayashi K,et al.Relationships of plasma inter leukin-18 concentrations to hyperhomocysteinemia and carotid intimamedia wall thickness in patients with type 2 diabetes[J].Diabetes Care,2003,26:2622-2627.
8Casals C,Arias_Diaz J,Valino F,et al.Surfactant streng thens the inhibitor y effect of C_reactive protein on human lung macro p hage c y tokine release[].American Journal of Physiology Lung Cellular and Molecular Physiology.2003
3Stanger BZ,Leder P,Lee TH,et al.RIP:a novel protein containing a death domain that interacts with Fas/APO-1(CD95)in yeast and causes cell death[J].Cell,1995,81(4):513-523.
5Cortelezzi A,Cattaneo C,Cristiani S,et al.Non-transferrin bound iron in myelodysplastic syndromes:a marker of ineffective erythropoiesis[J].Hematol J,2000,1(3):153-158.
